To get full valuation is the key. The big IF is if NWBO runs these trials for the other indications. It is doubtful they are the ones running these trials. I wouldn't calculate all other solid cancers into any valuation at this point. NWBO doesn't have the funds to run these trials. And partnerships means BP essentially funds the entire operations unless NWBO dilutes again. I think Buyout is the way brother. Let big brother run these other trials and take it to the finish line.